Literature DB >> 8170839

Characterization of peripheral benzodiazepine receptors in rat prostatic adenocarcinoma.

S Batra1, J Alenfall.   

Abstract

Using PK 11195, a high affinity ligand for peripheral benzodiazepine receptors (PBZr), binding sites in isolated mitochondrial (m-fraction) and microsomal fractions (p-fraction) from R-3327 Dunning AT-1 tumors, ventral and dorsolateral prostate were studied. Binding of PK 11195 in both m- and p-fractions from AT-1 tumors, but only in m-fraction from ventral and dorsolateral prostate, was specific, saturable, and of high affinity. The PBZr density in m-fraction from AT-1 tumor was 6-fold and 20-fold higher than that in ventral and dorsolateral prostate, respectively. The receptor density in p-fraction from AT-1 tumors was approximately 25% of that found in the m-fraction. Clear differences were observed in the competition by both diazepam and flunitrazepam for binding sites in m- and p-fractions from tumors. These data indicate that the receptors were not only localized to the mitochondria, but were also present in considerable amounts in the microsomal fractions. The unusually high amounts of receptors in the fast growing anaplastic prostatic tumor suggest their involvement in the regulation of cell proliferation and possibly in tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170839     DOI: 10.1002/pros.2990240509

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  5 in total

Review 1.  Mitochondrial cholesterol: mechanisms of import and effects on mitochondrial function.

Authors:  Laura A Martin; Barry E Kennedy; Barbara Karten
Journal:  J Bioenerg Biomembr       Date:  2014-11-26       Impact factor: 2.945

2.  Translocator Protein PET Imaging in a Preclinical Prostate Cancer Model.

Authors:  Mohammed N Tantawy; H Charles Manning; Todd E Peterson; Daniel C Colvin; John C Gore; Wenfu Lu; Zhenbang Chen; C Chad Quarles
Journal:  Mol Imaging Biol       Date:  2018-04       Impact factor: 3.488

3.  Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target.

Authors:  A Verma; S L Facchina; D J Hirsch; S Y Song; L F Dillahey; J R Williams; S H Snyder
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

4.  Translocator protein blockade reduces prostate tumor growth.

Authors:  Arlee Fafalios; Ardavan Akhavan; Anil V Parwani; Robert R Bies; Kevin J McHugh; Beth R Pflug
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

5.  Pharmacological evaluation of [123I]-CLINDE: a radioiodinated imidazopyridine-3-acetamide for the study of peripheral benzodiazepine binding sites (PBBS).

Authors:  Filomena Mattner; Karine Mardon; Andrew Katsifis
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-12-05       Impact factor: 9.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.